4.5 Article

Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Current role of antibody therapy in patients with metastatic colorectal cancer

P. Pfeiffer et al.

ONCOGENE (2007)

Review Pharmacology & Pharmacy

Metastatic colorectal cancer - Current systemic treatment options

Ruth E. Board et al.

Review Oncology

Oncologists' current opinion on the treatment of Colon carcinoma

Martin Majer et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)

Review Oncology

Adjuvant treatment of colon cancer: Past, present and future

J. Wils

JOURNAL OF CHEMOTHERAPY (2007)

Review Biotechnology & Applied Microbiology

Biological therapy update in colorectal cancer

Steven M. Sorscher

EXPERT OPINION ON BIOLOGICAL THERAPY (2007)

Review Biotechnology & Applied Microbiology

Bevacizumab in the treatment of colorectal cancer

MF Mulcahy et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2005)

Article Medicine, General & Internal

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

H Hurwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)